A Cell Therapy First: Comparison Study of patient-harvested Adipose Mesenchymal Stem Cells and commercially obtained AMSCs and BMSCs (bone marrow)
This study from the Johns Hopkins Departments of Neurosurgery and Oncology (PLOS ONE; Vol 8-3; March 2013) is crucial to the future of cell therapy in many different ways:
1) it compares autologous to allogeneic
2) it compares bone marrow MSCs to adipose
3) it assesses their tropism towards Glioma, a very common brain tumor.
Major findings and conclusions can be summarized as follows:
You can view the full research article here: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0058198